COMMUNIQUÉS West-GlobeNewswire

-
Curetis Announces Change of the Composition of Its Supervisory Board
30/04/2018 -
ABLYNX ANNOUNCES WARRANT EXERCISE
30/04/2018 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
30/04/2018 -
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
30/04/2018 -
Sanofi : FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé
30/04/2018 -
Addex Reports 2017 Full Year Results and Provides Corporate Update
30/04/2018 -
Innate Pharma to hold its AGM on May 29, 2018 and the release of its Reference document
30/04/2018 -
Innate Pharma annonce la tenue de son AG annuelle le 29 mai 2018 et la mise à disposition de son DDR 2017
30/04/2018 -
ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171
30/04/2018 -
Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018
30/04/2018 -
LADAVRU® RECEIVES APPROVED FOR PUBLICATON NOTICE FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HOVERINK BIOTECHNOLOGIES ANNOUNCES.
30/04/2018 -
Flexion Therapeutics Announces Presentation of Positive FX201 Data at the Osteoarthritis Research Society International World Congress
29/04/2018 -
HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT OF CONVERTIBLE NOTES
28/04/2018 -
AC Immune Announces Results of Extraordinary Shareholders Meeting
27/04/2018 -
OPKO Health to Remain on the Tel Aviv Stock Exchange
27/04/2018 -
Melinta Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018
27/04/2018 -
HTG Molecular Diagnostics to Announce First Quarter Financial Results and Host Conference Call on Thursday, May 10
27/04/2018 -
Aurora Spine Corporation Announces 2017 Year End Results
27/04/2018 -
MDxHealth releases 2017 Annual Report
27/04/2018
Pages